PE Ratio
2.88
-0.11-3.68%
Tue, 11 Feb 2025 21:07:38 GMT
Summary
- As of February 12, 2025, AGIO price to earnings ratio is 2.88, with a fall of -0.11 (-3.68%) during the most recent trading day.
- AGIO PE ratio is now -46.47% below its all-time high of 5.38.
Performance
AGIO PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
AGIO PE Ratio Trends
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -3.7% | -3.8% | +274.8% | +5.0% |
| 1 m1 month | -5.6% | -5.8% | - | - |
| 3 m3 months | -45.9% | -46.0% | +274.8% | +5.0% |
| 6 m6 months | - | -25.2% | - | - |
| ytdytd | +0.3% | +0.3% | - | - |
| 1 y1 year | - | +29.0% | +274.8% | +5.0% |
| 5 y5 years | - | -33.1% | +265.4% | +100.0% |
AGIO PE Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.7% | 2.81 | +2.5% | |
| 3 m | 3-month | 5.38 | -46.5% | 2.81 | +2.5% |
| 6 m | 6-month | 5.38 | -46.5% | 2.81 | +2.5% |
| 1 y | 1-year | 5.38 | -46.5% | 2.81 | +2.5% |
| 3 y | 3-year | 5.38 | -46.5% | 1.20 | +140.0% |
| 5 y | 5-year | 5.38 | -46.5% | 1.20 | +140.0% |
| alltime | all time | 5.38 | -46.5% | 1.20 | +140.0% |
Agios Pharmaceuticals PE Ratio History
| Date | Value |
|---|---|
| 2025 | 2.88(+0.3%) |
| Date | Value |
|---|---|
| 2024 | 2.87(+93.9%) |
| 2021 | 1.48 |
FAQ
- What is Agios Pharmaceuticals price to earnings ratio?
- What is the all time high PE ratio for Agios Pharmaceuticals?
- What is AGIO price to earnings ratio year-to-date change?
What is Agios Pharmaceuticals price to earnings ratio?
The current PE ratio of AGIO is 2.88
What is the all time high PE ratio for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high price to earnings ratio is 5.38
What is AGIO price to earnings ratio year-to-date change?
Agios Pharmaceuticals price to earnings ratio has changed by +0.01 (+0.35%) since the beginning of the year